Villar LM - Search Results

1

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Alenda R, Costa-Frossard L, Alvarez-Lafuente R, Espejo C, Rodríguez-Martín E, Sainz de la Maza S, Villarrubia N, Río J, Domínguez-Mozo MI, Montalban X, Álvarez-Cermeño JC, Villar LM. Alenda R, et al. Among authors: villar lm. J Neurol. 2018 Jan;265(1):32. doi: 10.1007/s00415-017-8679-5. J Neurol. 2018. PMID: 29177546

2

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.

Villar LM, Masjuan J, González-Porqué P, Plaza J, Sádaba MC, Roldán E, Bootello A, Alvarez-Cermeño JC. Villar LM, et al. Ann Neurol. 2003 Feb;53(2):222-6. doi: 10.1002/ana.10441. Ann Neurol. 2003. PMID: 12557289

3

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

Villar LM, Sádaba MC, Roldán E, Masjuan J, González-Porqué P, Villarrubia N, Espiño M, García-Trujillo JA, Bootello A, Alvarez-Cermeño JC. Villar LM, et al. J Clin Invest. 2005 Jan;115(1):187-94. doi: 10.1172/JCI22833. J Clin Invest. 2005. PMID: 15630459 Free PMC article.

4

Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.

Villar LM, Masjuan J, Sádaba MC, González-Porqué P, Plaza J, Bootello A, Alvarez-Cermeño JC. Villar LM, et al. Arch Neurol. 2005 Apr;62(4):574-7. doi: 10.1001/archneur.62.4.574. Arch Neurol. 2005. PMID: 15824255

5

Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.

Alvarez-Cermeño JC, Masjuan J, Villar LM. Alvarez-Cermeño JC, et al. Among authors: villar lm. N Engl J Med. 2005 Oct 20;353(16):1744-6; author reply 1744-6. N Engl J Med. 2005. PMID: 16240475 No abstract available.

6

Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis.

Villar LM, García-Barragán N, Sádaba MC, Espiño M, Gómez-Rial J, Martínez-San Millán J, González-Porqué P, Alvarez-Cermeño JC. Villar LM, et al. J Neurol Sci. 2008 Mar 15;266(1-2):34-7. doi: 10.1016/j.jns.2007.08.030. Epub 2007 Sep 19. J Neurol Sci. 2008. PMID: 17884100

7

Value of oligoclonal band study in clinically isolated syndromes and multiple sclerosis.

Alvarez-Cermeño JC, Gasalla T, Villar LM. Alvarez-Cermeño JC, et al. Among authors: villar lm. Expert Rev Neurother. 2008 Sep;8(9):1279-80. doi: 10.1586/14737175.8.9.1279. Expert Rev Neurother. 2008. PMID: 18759537 Review. No abstract available.

8

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.

Villar LM, Masterman T, Casanova B, Gómez-Rial J, Espiño M, Sádaba MC, González-Porqué P, Coret F, Alvarez-Cermeño JC. Villar LM, et al. J Neuroimmunol. 2009 Jun 25;211(1-2):101-4. doi: 10.1016/j.jneuroim.2009.03.003. Epub 2009 May 13. J Neuroimmunol. 2009. PMID: 19443047

9

Importance of age at diagnosis in multiple sclerosis.

Alvarez-Cermeño JC, Costa-Frossard L, Villar LM. Alvarez-Cermeño JC, et al. Among authors: villar lm. Expert Rev Neurother. 2010 Mar;10(3):341-2. doi: 10.1586/ern.10.10. Expert Rev Neurother. 2010. PMID: 20187856 No abstract available.

10

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

Comabella M, Fernández M, Martin R, Rivera-Vallvé S, Borrás E, Chiva C, Julià E, Rovira A, Cantó E, Alvarez-Cermeño JC, Villar LM, Tintoré M, Montalban X. Comabella M, et al. Among authors: villar lm. Brain. 2010 Apr;133(Pt 4):1082-93. doi: 10.1093/brain/awq035. Epub 2010 Mar 17. Brain. 2010. PMID: 20237129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters